November 11, 2021 •
New Jersey Requires Drug Utilization Review Board to Disclose Gifts
Public members of the state’s Drug Utilization Review Board are now required to file initial and quarterly disclosures reporting the financial benefits or interests they receive from members of the pharmaceutical industry.
Upon appointment, public members will need to report all meals, payments, gifts, salaries, stocks, or other investments they receive from pharmaceutical managers, pharmaceutical distributors, or pharmacy benefit managers in the preceding three years.
Members of the board will be required to update their financial disclosures quarterly, and reports will be publicly available.
State and Federal Communications, Inc. provides research and consulting services for government relations professionals on lobbying laws, procurement lobbying laws, political contribution laws in the United States and Canada. Learn more by visiting stateandfed.com.